U.S. Markets close in 2 hrs 45 mins

Merus Labs International Inc. (MSLI)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.1866+0.01 (+0.56%)
As of 12:57PM EDT. Market open.
People also watch
PRPHNEPTMNOVMTSLMEIP

Merus Labs International Inc.

100 Wellington Street West
Suite 2110
Toronto, ON M5K 1H1
Canada
416-593-3725
http://www.meruslabs.com

Sector
Industry
Full Time Employees13

Key Executives

NameTitlePayExercisedAge
Mr. Barry FishmanChief Exec. Officer, Pres and Director381.11kN/A60
Dr. Michael Scott BumbyChief Financial Officer71.54kN/A53
Mr. Frank FokkingaVP of Global Regulatory Affairs, Quality and Compliance83.6kN/AN/A
Mr. Frank RotmannHead of European Operations and VP355.51kN/AN/A
Mr. Geoff MorrowVP of Bus. Devel.160.59kN/AN/A
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Merus Labs International Inc., a specialty pharmaceutical company, owns, markets, and distributes pharmaceutical products primarily in Europe and Canada. The company offers Elantan, Isoket, and Deponit nitrates for acute and chronic coronary artery disease; Sintrom for the treatment and prevention of thromboembolism diseases; Emselex/Enablex, for the treatment of overactive bladder syndrome; Surgestone and Provames for various health indications in women’s; Speciafoldine for macrocytic anemia; and Tredemine for tapeworm. It also provides Salagen for the treatment of symptoms of dry eye and dry mouth disorders, as well as for xerostomia following radiation therapy; Estraderm MX for the treatment of signs and symptoms of estrogen deficiency due to menopause, and for the prevention of accelerated postmenopausal bone loss; and Vancocin for the treatment of gastrointestinal tract bacterial infections. The company is headquartered in Toronto, Canada.

Corporate Governance

Merus Labs International Inc.’s ISS Governance QualityScore as of May 1, 2017 is 7. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 6; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.